换一批Analysis of Patent and Regulatory Exclusivity for Novel Agents in China and the United States: A Cohort Study of Drugs Approved Between 2018 and 2021.
第一作者：
Xingxian,Luo
第一单位：
School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.;Institute of Pharmaceutical Regulatory Sciences, Tsinghua University, Beijing, China.;Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China.
作者：
主题词
中国(China);队列研究(Cohort Studies);制药工业(Drug Industry);人类(Humans);美国(United States);美国食品和药物管理局(United States Food and Drug Administration)
DOI
10.1002/cpt.2625
PMID
35485980
发布时间
2022-09-12
- 浏览36
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
